Form 4: J&J Executive Wengel Reports 13,706 PSU Vesting

Johnson & Johnson's EVP, Chief TO and Risk Officer, Kathryn E. Wengel, reported the vesting of 13,706 Performance Share Units.

Summary

• Kathryn E. Wengel, Executive Vice President, Chief Technical Operations and Risk Officer at Johnson & Johnson (JNJ), reported a change in beneficial ownership.
• The filing details the acquisition of 13,706 Performance Share Units (PSUs) through vesting.
• These PSUs were originally awarded under the company's Long-Term Incentive Plan on February 13, 2023.
• The number of PSUs reflects the target amount, adjusted based on the achievement of performance conditions, which were certified on February 9, 2026.
• Upon vesting, these PSUs convert into an equal number of Common Stock shares, with the date exercisable being February 13, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, indicating successful achievement of performance targets for executive compensation, which generally reflects well on the company's operational execution over the performance period.

Positives

• The vesting of Performance Share Units indicates that the performance conditions set forth in the award agreement were met, suggesting positive company performance over the award period.
• The executive's continued direct beneficial ownership of 13,706 derivative securities (PSUs) aligns her interests with those of shareholders.

Future Outlook

The filing indicates the future conversion of 13,706 Performance Share Units into Johnson & Johnson Common Stock on February 13, 2026, contingent on the terms of the award agreement.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for executive compensation and insider transactions. The vesting of Performance Share Units is a common component of long-term incentive plans in large pharmaceutical and consumer health companies like Johnson & Johnson, designed to align executive performance with shareholder value over multi-year periods.

Comparison to Industry Standards

• The use of Performance Share Units (PSUs) as a long-term incentive is a common practice among S&P 500 companies, including peers like Pfizer, Merck, and Abbott Laboratories, which also tie executive compensation to multi-year performance metrics.
• The reported vesting of 13,706 PSUs for an EVP-level executive is within the typical range for such roles in large-cap companies, reflecting a significant but not extraordinary equity award.

Stakeholder Impact

• Shareholders: The vesting of PSUs, tied to performance, suggests management's interests are aligned with shareholder value creation. The conversion will slightly increase the number of outstanding shares, but this is a planned part of executive compensation.
• Employees: Reflects the company's established long-term incentive programs for executives.

Next Steps

• Conversion of 13,706 Performance Share Units into Common Stock on February 13, 2026.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (vesting of PSUs) and does not provide new fundamental information about Johnson & Johnson's operational performance or strategic direction that would warrant a change in investment recommendation. It confirms that performance targets were met, which is a positive, but not a catalyst for a 'buy' given it's a pre-scheduled event. Therefore, a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Johnson & Johnson, JNJ, Form 4, Insider Trading, Performance Share Units, PSUs, Executive Compensation, Beneficial Ownership, Kathryn E. Wengel